Handling Insulin-Related Emotions Sanjay KalraKomal Verma Editorial Open access 28 May 2018 Pages: 1415 - 1419
Diabetes Fatigue Syndrome Sanjay KalraRakesh Sahay Editorial Open access 04 June 2018 Pages: 1421 - 1429
Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments W. Ryan PowellCindy L. ChristiansenDonald R. Miller Review Open access 28 May 2018 Pages: 1431 - 1440
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects Valentin DemmelAnne Sandberg-SchaalAnne Flint Original Research Open access 24 May 2018 Pages: 1441 - 1456
Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population Fei SunBin GaoQiuhe Ji Original Research Open access 28 May 2018 Pages: 1457 - 1468
Similar Intrapatient Blood Glucose Variability with LY2963016 and LantusĀ® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation Hiroshi NishiyamaTomotaka ShingakiLiza L. Ilag Original Research Open access 31 May 2018 Pages: 1469 - 1476
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study Gian Paolo FadiniDaniele BottigliengoOn behalf of the DARWIN-T2D Network Original Research Open access 01 June 2018 Pages: 1477 - 1490
Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons Chakrapani BalijepalliRohan ShiraliEric Druyts Original Research Open access 12 June 2018 Pages: 1491 - 1500
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study Akiko NishimuraShin-ichi HarashimaNobuya Inagaki Original Research Open access 12 June 2018 Pages: 1501 - 1510
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss Maria J. PereiraPer LundkvistJan W. Eriksson Original Research Open access 13 June 2018 Pages: 1511 - 1532
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis Kristin Cecilie Carlsson PetriSteen Hvass IngwersenRune Viig Overgaard Original Research Open access 15 June 2018 Pages: 1533 - 1547
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study Hisamitsu IshiharaSusumu YamaguchiTaishi Sakatani Original Research Open access 20 June 2018 Pages: 1549 - 1567
There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study Tomoe KinoshitaMasashi ShimodaHideaki Kaneto Original Research Open access 21 June 2018 Pages: 1569 - 1580
Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials Annaswamy RajiJianmin LongSamuel S. Engel Original Research Open access 23 June 2018 Pages: 1581 - 1589
Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial Mats De JaegerLisa GoudmanMaarten Moens Original Research Open access 27 June 2018 Pages: 1591 - 1604
Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial Wei LiFan PingYuxiu Li Original Research Open access 27 June 2018 Pages: 1605 - 1614
Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire Selcuk DagdelenOguzhan Deynelithe ITQ Turkish Study Group Original Research Open access 30 June 2018 Pages: 1615 - 1628
Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire Selcuk DagdelenOguzhan Deynelithe ITQ Turkish Study Group Original Research Open access 30 June 2018 Pages: 1629 - 1645
Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial Ameer KhowajaJamil B. AlkhaddoLisa Fish Original Research Open access 30 June 2018 Pages: 1647 - 1655
Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries Goran PetrovskiDashamir GjergjiNatasa Grulovic Original Research Open access 03 July 2018 Pages: 1657 - 1668
The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis Chenfang WuDiling WuYanjun Zhong Original Research Open access 09 July 2018 Pages: 1669 - 1688
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea Eugene HanAri KimByung-Wan Lee Original Research Open access 11 July 2018 Pages: 1689 - 1701
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes Chantal MathieuDoina CatrinoiuAleksander CeliƱski Brief Report Open access 25 May 2018 Pages: 1703 - 1711
Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review Zhihui DengJohn DavisFran Richardson Case Report Open access 28 May 2018 Pages: 1713 - 1718
Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Hitoshi IshiiKoki ShinYasuhiro Akai Correction Open access 16 June 2018 Pages: 1719 - 1719
Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study Ian J. NeelandDarren K. McGuireOdd Erik Johansen Correction Open access 21 June 2018 Pages: 1721 - 1721